N. Roche and A. J. , Soria is a consultant/advisory board member for AstraZeneca

J. Fu, J. Garrabey, L. Soria, F. Lacroix, C. Andr-e et al., Lefebvre Development of methodology Lefebvre Acquisition of data (provided animals, acquired and managed patients, provided facilities Lacroix Analysis and interpretation of data (e.g., statistical analysis, biostatistics, computational analysis

F. Soria, C. Andr-e, P. Jia, F. Li, H. Chen et al., Lefebvre Administrative, technical, or material support (i.e., reporting or organizing data, constructing databases) Detecting somatic point mutations in cancer genome sequencing data: a comparison of mutation callers, Genome Med, vol.5, p.91, 2013.

M. Ignatiadis and S. Dawson, Circulating tumor cells and circulating tumor DNA for precision medicine: dream or reality?, Annals of Oncology, vol.25, issue.12, pp.2304-2317, 2014.
DOI : 10.1093/annonc/mdu480

C. Bettegowda, M. Sausen, R. Leary, I. Kinde, Y. Wang et al., Detection of circulating tumor DNA in early-and late-stage human malignancies, Sci Transl Med, vol.6, pp.224-248, 2014.

F. Diehl, K. Schmidt, M. Choti, K. Romans, S. Goodman et al., Circulating mutant DNA to assess tumor dynamics, Nature Medicine, vol.3, issue.9, pp.985-90, 2008.
DOI : 10.1038/nm.1789

K. Spindler, N. Pallisgaard, R. Andersen, I. Brandslund, and A. Jakobsen, Circulating Free DNA as Biomarker and Source for Mutation Detection in Metastatic Colorectal Cancer, PLOS ONE, vol.34, issue.2, p.108247, 2015.
DOI : 10.1371/journal.pone.0108247.t002

D. Haber and V. Velculescu, Blood-Based Analyses of Cancer: Circulating Tumor Cells and Circulating Tumor DNA, Cancer Discovery, vol.4, issue.6, pp.650-61, 2014.
DOI : 10.1158/2159-8290.CD-13-1014

R. Leary, I. Kinde, F. Diehl, K. Schmidt, C. Clouser et al., Development of Personalized Tumor Biomarkers Using Massively Parallel Sequencing, Science Translational Medicine, vol.2, issue.20, pp.20-34, 2010.
DOI : 10.1126/scitranslmed.3000702

D. Mcbride, A. Orpana, C. Sotiriou, H. Joensuu, P. Stephens et al., Use of cancer-specific genomic rearrangements to quantify disease burden in plasma from patients with solid tumors, Genes, Chromosomes and Cancer, vol.15, issue.11, pp.1062-1071, 2010.
DOI : 10.1002/gcc.20815

C. Jovelet, E. Ileana, L. Deley, M. Mott-e, N. Rosellini et al., Circulating Cell-Free Tumor DNA Analysis of 50 Genes by Next-Generation Sequencing in the Prospective MOSCATO Trial, Clinical Cancer Research, vol.22, issue.12, pp.2960-2968, 2016.
DOI : 10.1158/1078-0432.CCR-15-2470

L. Alexandrov, S. Nik-zainal, D. Wedge, S. Aparicio, S. Behjati et al., Signatures of mutational processes in human cancer, Nature, vol.27, issue.7463, pp.415-436, 2013.
DOI : 10.1038/nature12477

A. Ewing, K. Houlahan, Y. Hu, K. Ellrott, C. Caloian et al., Combining tumor genome simulation with crowdsourcing to benchmark somatic single-nucleotide-variant detection, Nature Methods, vol.9, issue.7, pp.623-653, 2015.
DOI : 10.1073/pnas.1530509100

S. Clopper and E. Pearson, THE USE OF CONFIDENCE OR FIDUCIAL LIMITS ILLUSTRATED IN THE CASE OF THE BINOMIAL, Biometrika, vol.26, issue.4, pp.404-417, 1934.
DOI : 10.1093/biomet/26.4.404

F. Andre, T. Bachelot, F. Commo, M. Campone, M. Arnedos et al., Comparative genomic hybridisation array and DNA sequencing to direct treatment of metastatic breast cancer: a multicentre, prospective trial (SAFIR01/UNICANCER), The Lancet Oncology, vol.15, issue.3, pp.267-74, 2014.
DOI : 10.1016/S1470-2045(13)70611-9

H. Li and R. Durbin, Fast and accurate long-read alignment with Burrows-Wheeler transform, Bioinformatics, vol.26, issue.5, pp.589-95, 2010.
DOI : 10.1093/bioinformatics/btp698

H. Li, B. Handsaker, A. Wysoker, T. Fennell, J. Ruan et al., The Sequence Alignment/Map format and SAMtools, Bioinformatics, vol.25, issue.16, pp.2078-2087, 2009.
DOI : 10.1093/bioinformatics/btp352

P. Cingolani, A. Platts, L. Wang-le, M. Coon, T. Nguyen et al., A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff, Fly, vol.8, issue.2, pp.80-92, 2012.
DOI : 10.1101/gr.4086505

V. Bansal, A statistical method for the detection of variants from next-generation resequencing of DNA pools, Bioinformatics, vol.26, issue.12, pp.318-342, 2010.
DOI : 10.1093/bioinformatics/btq214

G. Abecasis, A. Auton, L. Brooks, M. Depristo, R. Durbin et al., An integrated map of genetic variation from 1,092 human genomes, Nature, vol.491, pp.56-65, 2012.

A. Mckenna, M. Hanna, E. Banks, A. Sivachenko, K. Cibulskis et al., The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data, Genome Research, vol.20, issue.9, pp.1297-303, 2010.
DOI : 10.1101/gr.107524.110

S. Forbes, D. Beare, P. Gunasekaran, K. Leung, N. Bindal et al., COSMIC: exploring the world's knowledge of somatic mutations in human cancer, Nucleic Acids Research, vol.43, issue.D1, pp.805-816, 2015.
DOI : 10.1093/nar/gku1075

K. Cibulskis, M. Lawrence, S. Carter, A. Sivachenko, D. Jaffe et al., Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples, Nature Biotechnology, vol.27, issue.3, pp.213-222, 2013.
DOI : 10.1038/nature09515

D. Koboldt, Q. Zhang, D. Larson, D. Shen, M. Mclellan et al., VarScan 2: Somatic mutation and copy number alteration discovery in cancer by exome sequencing, Genome Research, vol.22, issue.3, pp.568-76, 2012.
DOI : 10.1101/gr.129684.111

S. Dawson, D. Tsui, M. Murtaza, H. Biggs, O. Rueda et al., Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer, New England Journal of Medicine, vol.368, issue.13, pp.1199-209, 2013.
DOI : 10.1056/NEJMoa1213261

F. Bidard, D. Peeters, T. Fehm, F. Nol-e, R. Gisbert-criado et al., Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data, The Lancet Oncology, vol.15, issue.4, pp.406-420, 2014.
DOI : 10.1016/S1470-2045(14)70069-5